HER2 Targeted HypoSti.CAR-T Cells in HER2 Positive Advanced Solid Tumors
Clinical trial NCT05681650 · RECRUITING
Trial details
- NCT number
- NCT05681650
- Sponsor
- Chinese PLA General Hospital
- Status
- RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-10-11
- Primary completion
- 2025-12-31
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.